XML 156 R24.htm IDEA: XBRL DOCUMENT v3.22.4
Segment Information
 12 Months Ended
Dec. 31, 2022
Segment Reporting [Abstract]  
Segment Information Segment Information
The Company operates in two product segments: Oral, Personal and Home Care; and Pet Nutrition. 

The operations of the Oral, Personal and Home Care product segment are managed geographically in five reportable operating segments: North America, Latin America, Europe, Asia Pacific and Africa/Eurasia.

The Company evaluates segment performance based on several factors, including Operating profit. The Company uses Operating profit as a measure of operating segment performance because it excludes the impact of Corporate-driven decisions related to interest expense and income taxes.

The accounting policies of the operating segments are generally the same as those described in Note 2, Summary of Significant Accounting Policies. Intercompany sales have been eliminated. Corporate operations include costs related to stock options and restricted stock units, research and development costs, Corporate overhead costs, restructuring and related implementation charges and gains and losses on sales of non-core product lines and assets. The Company reports these items within Corporate operations as they relate to Corporate-based responsibilities and decisions and are not included in the internal measures of segment operating performance used by the Company to measure the underlying performance of the operating segments.

Approximately two-thirds of the Company’s Net sales are generated from markets outside the U.S., with approximately 45% of the Company’s Net sales coming from emerging markets (which consist of Latin America, Asia (excluding Japan), Africa/Eurasia and Central Europe). Oral, Personal and Home Care sales to Walmart, Inc. and its affiliates represent approximately 11%, 12% and 12% of the Company’s Net sales in 2022, 2021 and 2020, respectively. No other customer represented more than 10% of Net sales in any period presented.

In 2022, Corporate Operating profit included goodwill and intangible assets impairment charges of $721, charges resulting from the 2022 Global Productivity Initiative of $95, a gain on the sale of land in Asia Pacific of $47 and acquisition-related costs of $19. In 2021, Corporate Operating profit included goodwill and intangible assets impairment charges of $571, and a benefit of $26 related to a value-added tax matter in Brazil. In 2020, Corporate Operating profit included benefits of $16 resulting from the Global Growth and Efficiency Program and acquisition-related costs of $6.
 202220212020
Net sales  
Oral, Personal and Home Care  
North America(1)
$3,816 $3,694 $3,741 
Latin America3,982 3,663 3,418 
Europe2,548 2,841 2,747 
Asia Pacific2,826 2,867 2,701 
Africa/Eurasia1,082 1,045 981 
Total Oral, Personal and Home Care14,254 14,110 13,588 
Pet Nutrition(2)
3,713 3,311 2,883 
Total Net sales$17,967 $17,421 $16,471 
_________
(1)    Net sales in the U.S. for Oral, Personal and Home Care were $3,511, $3,391 and $3,447 in 2022, 2021 and 2020, respectively.
(2)    Net sales in the U.S. for Pet Nutrition were $2,432, $2,018 and $1,712 in 2022, 2021 and 2020, respectively.
202220212020
Operating profit  
Oral, Personal and Home Care  
North America$761 $754 $988 
Latin America1,108 1,012 975 
Europe514 682 652 
Asia Pacific737 844 773 
Africa/Eurasia228 203 206 
Total Oral, Personal and Home Care3,348 3,495 3,594 
Pet Nutrition850 901 793 
Corporate(1,305)(1,064)(502)
Total Operating profit$2,893 $3,332 $3,885 

202220212020
Capital expenditures  
Oral, Personal and Home Care  
North America$66 $87 $65 
Latin America121 118 104 
Europe31 44 41 
Asia Pacific60 50 51 
Africa/Eurasia30 33 13 
Total Oral, Personal and Home Care308 332 274 
Pet Nutrition297 147 56 
Corporate91 88 79 
Total Capital expenditures$696 $567 $409 

202220212020
Depreciation and amortization  
Oral, Personal and Home Care  
North America$106 $104 $101 
Latin America93 88 81 
Europe90 98 94 
Asia Pacific89 96 95 
Africa/Eurasia9 9 9 
Total Oral, Personal and Home Care387 395 380 
Pet Nutrition65 62 58 
Corporate93 99 101 
Total Depreciation and amortization$545 $556 $539 
202220212020
Identifiable assets
Oral, Personal and Home Care   
North America$4,012 $4,058 $4,132 
Latin America2,603 2,369 2,251 
Europe3,457 4,432 5,386 
Asia Pacific2,085 2,161 2,272 
Africa/Eurasia694 599 605 
Total Oral, Personal and Home Care12,851 13,619 14,646 
Pet Nutrition2,804 1,342 1,210 
Corporate(1)
76 79 64 
Total Identifiable assets$15,731 $15,040 $15,920 
____________
(1)In 2022, Corporate identifiable assets primarily consisted of investments in equity securities (95%). In 2021, Corporate identifiable assets primarily consisted of investments in equity securities (87%) and derivative instruments (10%). In 2020, Corporate identifiable assets primarily consisted of investments in equity securities (95%). 

202220212020
Long-lived assets(1)
United States$2,569 $1,981 $1,889 
International2,216 2,275 2,348 
Total Long-lived assets$4,785 $4,256 $4,237 
____________
(1)Long-lived assets include Property, plant and equipment, net and lease right-of-use assets.